Novo Integrated Sciences Inc (NVOS)
0.8006
+0.02
(+2.68%)
USD |
NASDAQ |
Jun 27, 16:00
0.7899
-0.01
(-1.34%)
After-Hours: 20:00
Novo Integrated Sciences Cash from Financing (Quarterly): 0.0032M for Feb. 29, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | 0.0032M |
| November 30, 2023 | 3.296M |
| August 31, 2023 | 0.4675M |
| May 31, 2023 | 0.901M |
| February 28, 2023 | 0.4293M |
| November 30, 2022 | -1.034M |
| August 31, 2022 | -11.23M |
| May 31, 2022 | -0.0372M |
| February 28, 2022 | 9.440M |
| November 30, 2021 | 1.400M |
| August 31, 2021 | -2.845M |
| May 31, 2021 | 7.141M |
| February 28, 2021 | -0.0223M |
| November 30, 2020 | 0.0436M |
| August 31, 2020 | -0.3156M |
| May 31, 2020 | 0.0709M |
| February 29, 2020 | -0.0571M |
| November 30, 2019 | 0.0301M |
| August 31, 2019 | -0.0031M |
| May 31, 2019 | 0.6393M |
| February 28, 2019 | 1.940M |
| November 30, 2018 | 0.4974M |
| August 31, 2018 | 0.0115M |
| May 31, 2018 | 0.2474M |
| February 28, 2018 | -0.0866M |
| Date | Value |
|---|---|
| November 30, 2017 | -0.1839M |
| March 31, 2017 | 0.015M |
| December 31, 2016 | 0.065M |
| September 30, 2016 | 0.015M |
| June 30, 2016 | 0.03M |
| March 31, 2016 | 0.04M |
| December 31, 2015 | 0.02M |
| September 30, 2015 | 0.05M |
| June 30, 2015 | 0.085M |
| March 31, 2015 | 0.0329M |
| December 31, 2014 | 0.0375M |
| September 30, 2014 | 0.0366M |
| June 30, 2014 | 0.0195M |
| March 31, 2014 | 0.0508M |
| December 31, 2013 | 0.0432M |
| September 30, 2013 | 0.0708M |
| June 30, 2013 | 0.065M |
| March 31, 2013 | 0.0675M |
| December 31, 2012 | 0.0275M |
| September 30, 2012 | 0.0675M |
| June 30, 2012 | 0.1204M |
| March 31, 2012 | 0.3419M |
| December 31, 2011 | 0.0475M |
| September 30, 2011 | 0.0368M |
| June 30, 2011 | 0.0648M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-11.23M
Minimum
Aug 2022
9.440M
Maximum
Feb 2022
0.4041M
Average
0.0301M
Median
Nov 2019
Cash from Financing (Quarterly) Benchmarks
| American Shared Hospital Services | 2.282M |
| Astrana Health Inc | 106.35M |
| Cryo-Cell International Inc | 0.539M |
| P3 Health Partners Inc | 11.40M |
| Biote Corp | -5.409M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.714M |
| Free Cash Flow | -4.952M |
| Free Cash Flow Per Share (Quarterly) | -0.0971 |
| Free Cash Flow to Equity (Quarterly) | -2.360M |
| Free Cash Flow to Firm (Quarterly) | -0.4628M |
| Free Cash Flow Yield | -38.88% |